<DOC>
	<DOCNO>NCT01616160</DOCNO>
	<brief_summary>Aim 1 : To assess steroid sensitivity mometasone furoate ( MF ) culture nasal polyp explant tissue vitro . Aim 2 : To assess steroid sensitivity vivo subject compare symptom score , nasal endoscopic finding follow 4 week treatment mometasone furoate nasal spray ( MFNS ) compare tissue immunohistology NP biopsies pre- post-treatment withA MFNS . Aim 3 : To characterize molecular signature gene mRNA expression `` steroid-sensitive '' `` steroid-resistant '' NP use microarray NP tissue pre- post-MFNS treatment . Hypothesis 1 : Genes regulate apoptosis dysregulated nasal polyp ( NP ) inflammatory cell , epithelial cell smooth muscle actin myofibroblasts lead persistence inflammatory cell infiltration abnormal epithelial myofibroblast cellular proliferation . These correct mometasone . Apoptosis-regulating gene correct mometasone upregulated steroid-resistant NP . Elucidation dysregulation may prove insightful understanding mechanism action mometasone NP identify potential molecular target increase steroid sensitivity , conversely , overcome steroid resistance . Hypothesis 2 : There molecular signature gene expression NP signify steroid sensitive NP ( SS-NP ) . This signature alter steroid resistant NP ( SR-NP ) . Elucidation difference molecular signature SS-NP versus SR-NP treatment mometasone furoate ( MFNS ) provide novel insight treatment NP steroid .</brief_summary>
	<brief_title>An Open-label Study Identify Molecular Markers Steroid Resistance</brief_title>
	<detailed_description />
	<mesh_term>Nasal Polyps</mesh_term>
	<mesh_term>Mometasone Furoate</mesh_term>
	<criteria>The subject must fulfill follow condition characteristic consider enrollment : 1 . Male female age 21 70 year reside Boston area 2 . History chronic rhinosinusitis ( symptom least 3 month ) . Subject must two follow : Facial pain/pressure headache Nasal congestion Anterior posterior nasal drainage Hyposmia/anosmia 3 . Abnormal CT scan least 2 sinus area within 3 month 4 . Evidence bilateral polyp polypoid mucosa ( nasal endoscopy ) minimum polyp/polypoid score 4 ( see score system ) . 4 . History suggestive immunodeficiency ( i.e . &gt; one pneumonia past 12 month know immune deficiency ) . 5 . History cystic fibrosis , Kartagener 's syndrome , immotile cilium syndrome , hypogammaglobulinemia bleed disorder 6 . URI within six week prior enrollment 7 . Intranasal cocaine use 8 . Pregnancy ( applicable 9 . History faint MEDICATION EXCLUSIONS prior NP biopsy : 10 . Use prescription blood thinner 11 . Use systemic glucocorticoid two week prior enrollment 12 . Use intranasal corticosteroid anticholinergic three day prior enrollment 13 . Use antibiotic three day prior enrollment 14 . Use antihistamine one week prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Nasal polyp</keyword>
</DOC>